Literature DB >> 19295161

The cleavage products of amyloid-beta precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites.

Virgil Muresan1, Nicholas H Varvel, Bruce T Lamb, Zoia Muresan.   

Abstract

The amyloid-beta (Abeta) precursor protein (APP), a transmembrane protein that undergoes proteolytic cleavage into defined fragments, has been implicated in axonal transport. The proposed role of APP as a vesicle receptor for the microtubule motor kinesin-1 has relevance for the pathogenesis of Alzheimer's disease. Nevertheless, this function, which relies on the transport to the cell periphery of full-length APP rather than its cleavage fragments, remains controversial. Other proposed functions of APP, such as regulating transcription, neurogenesis, cell movement, or neurite growth also rely on APP's presence as a full-length protein at the cell surface, implying that APP cleavage occurs after its transport to the cell periphery. To test this hypothesis, we mapped the localization of various APP epitopes in neurons in culture and in the mouse brain. Surprisingly, epitopes from the N-terminal, C-terminal, and central (Abeta) domains of APP each showed a distinct distribution throughout the cell and rarely colocalized. Within neurites, these epitopes were localized to distinct transport vesicles that associated with different sets of microtubules and, occasionally, actin filaments. C-terminal APP fragments were preferentially transported into neurites as phosphorylated forms, entered the lamellipodium and filopodia of growth cones, and concentrated in regions of growth cone turning and advancement (unlike the N-terminal and Abeta fragments). We conclude that, under normal conditions, the proteolytic cleavage of APP primarily occurs before its sorting into axonal transport vesicles and the cleaved fragments segregate into separate vesicle populations that reach different destinations, and thus have different functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295161      PMCID: PMC2669751          DOI: 10.1523/JNEUROSCI.2558-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

1.  Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice.

Authors:  Orly Lazarov; Michael Lee; Daniel A Peterson; Sangram S Sisodia
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

2.  Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus.

Authors:  A Kinoshita; C M Whelan; C J Smith; O Berezovska; B T Hyman
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

3.  The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo.

Authors:  Shasta L Sabo; Annat F Ikin; Joseph D Buxbaum; Paul Greengard
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 4.  Tubulin structure and biochemistry.

Authors:  R F Ludueña; A Banerjee; I A Khan
Journal:  Curr Opin Cell Biol       Date:  1992-02       Impact factor: 8.382

5.  A phosphorylated, carboxy-terminal fragment of beta-amyloid precursor protein localizes to the splicing factor compartment.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Hum Mol Genet       Date:  2004-01-13       Impact factor: 6.150

6.  Alterations in beta-amyloid production and deposition in brain regions of two transgenic models.

Authors:  Emily J H Lehman; Laura Shapiro Kulnane; Bruce T Lamb
Journal:  Neurobiol Aging       Date:  2003-09       Impact factor: 4.673

7.  Conventional kinesin holoenzymes are composed of heavy and light chain homodimers.

Authors:  Scott R DeBoer; YiMei You; Anita Szodorai; Agnieszka Kaminska; Gustavo Pigino; Evelyn Nwabuisi; Bin Wang; Tatiana Estrada-Hernandez; Stefan Kins; Scott T Brady; Gerardo Morfini
Journal:  Biochemistry       Date:  2008-03-25       Impact factor: 3.162

8.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

Authors:  A Weidemann; G König; D Bunke; P Fischer; J M Salbaum; C L Masters; K Beyreuther
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

9.  Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease.

Authors:  I Grundke-Iqbal; K Iqbal; L George; Y C Tung; K S Kim; H M Wisniewski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  APP processing is regulated by cytoplasmic phosphorylation.

Authors:  Ming-Sum Lee; Shih-Chu Kao; Cynthia A Lemere; Weiming Xia; Huang-Chun Tseng; Ying Zhou; Rachael Neve; Michael K Ahlijanian; Li-Huei Tsai
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  43 in total

1.  Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI.

Authors:  Joseph J Gallagher; Xiaowei Zhang; Gregory J Ziomek; Russell E Jacobs; Elaine L Bearer
Journal:  Neuroimage       Date:  2012-02-10       Impact factor: 6.556

2.  Imaging the Intracellular Trafficking of APP with Photoactivatable GFP.

Authors:  Joshua H K Tam; Stephen H Pasternak
Journal:  J Vis Exp       Date:  2015-10-17       Impact factor: 1.355

3.  Functional interaction between amyloid-β precursor protein and peripherin neurofilaments: a shared pathway leading to Alzheimer's disease and amyotrophic lateral sclerosis?

Authors:  Virgil Muresan; Christine Villegas; Zoia Ladescu Muresan
Journal:  Neurodegener Dis       Date:  2013-09-04       Impact factor: 2.977

4.  Dual-tagged amyloid-β precursor protein reveals distinct transport pathways of its N- and C-terminal fragments.

Authors:  Christine Villegas; Virgil Muresan; Zoia Ladescu Muresan
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

5.  Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy.

Authors:  Sooyeon Lee; Yutaka Sato; Ralph A Nixon
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

6.  Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer's disease model.

Authors:  Ashley A Johnson; Jessica Sarthi; Sheila K Pirooznia; William Reube; Felice Elefant
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

7.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

8.  Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo.

Authors:  Shermali Gunawardena; Ge Yang; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2013-05-24       Impact factor: 6.150

9.  UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport.

Authors:  Angels Almenar-Queralt; Tomas L Falzone; Zhouxin Shen; Concepcion Lillo; Rhiannon L Killian; Angela S Arreola; Emily D Niederst; Kheng S Ng; Sonia N Kim; Steven P Briggs; David S Williams; Lawrence S B Goldstein
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

10.  Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo.

Authors:  John W Steele; Soong H Kim; John R Cirrito; Deborah K Verges; Jessica L Restivo; David Westaway; Paul Fraser; Peter St George Hyslop; Mary Sano; Ilya Bezprozvanny; Michelle E Ehrlich; David M Holtzman; Sam Gandy
Journal:  Mol Neurodegener       Date:  2009-12-17       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.